Days

400 +

Participants

80 +

Pharma Companies

60 +

Solution Providers

20 +

Authoritative Speakers

10h +

Networking

20 +

Exhibition Booth

Organizer

Supporters

Click-to-Play GPSCS2025 Video

Summit Background

Currently, China's drug circulation industry is undergoing profound policy adjustments and market transformations. A series of critical policies have not only reshaped the competitive landscape but also placed unprecedented higher demands on the efficiency, resilience, and compliance of pharma supply chain. Meanwhile, the wave of digital and intelligent technologies, represented by AI, big data and the IoT, is driving comprehensive transformation across pharma R&D, manufacturing and distribution.

Against this dual backdrop, the core of pharma supply chain management has rapidly expanded from traditional cost and efficiency-oriented approach to a complex system that encompasses full-chain traceability, network optimization, resilience & agility, E2E visibility, global operations, and full lifecycle management.

GPSCS2026 will focus on four major dimensions:"Regulatory Compliance, Resilience & Agility, Cost & Efficiency, and Digital Intelligent Transformation", and delve into the full-chain upgrade and optimization from clinical trials, commercialization, manufacturing to circulation & distribution. We will jointly dissect cutting-edge practices and future trends, providing key insights and action guidelines for enterprises to build sustainable competitive advantages.

Attendee Structure

Past Speakers

Ken Qiu

VP, Head of Supply Chain

Innovent Biologics

HongBo Wen

Associate GM, Supply Chain

Fosun Pharma

Alex Xu

Associate Director - Global Logistics Asia

Eli Lilly

Gary Lu

Senior Director, SHE and Sustainability, Supply APAC & Japan

AstraZeneca

Clark Sun

Operations Head

Sanofi Pasteur

Jacky Tan

Pharma Supply Chain Expert

JianYun Zhu

Supply Chain Policy Expert of Shanghai Food and Drug Safety Research Association

Member of Drug Circulation Regulatory Committee of China Society for Drug Regulation

Qi Jiang

Chief Supply Chain Expert & Director of Greater China

BCI Global

Pascal Wolff

Associate Professor

Ningbo China Institute for Supply Chain Innovation (NISCI)

HePing Wang

GM of the 5th BU

New Trend International

Dale Dai

Senior Manager

Ernst & Young

More Information on Speakers

TOPICS OVERVIEW

21stMay: Policy & Regulation; SC Strategy; Modern Logistics; Full-chain Traceability; Network Optimization; SC Layout; E2E Visibility; Resilience & Agility;
Logistics & SC Efficiency; Digital & AI

Morning:Policy & Regulation; SC Strategy; Modern Logistics; Full-chain Traceability; Network Optimization

  ·  Policy Evolution of Drug Circulation Industry and Development Trends of Pharma Supply Chain
  ·  Supply Chain Strategy Reconstruction and Future Layout under the Background of Digital and intelligent Transformation of the Pharma Industry
  ·  Building a Future-oriented Modern Pharma Logistics and Full-chain Traceability System
  ·  From Compliance to Excellence: Optimization of Pharma Cold Chain Logistics Management and Supply Chain Network Layout
  ·  Panel Discussion: Pharma Supply Chain Transformation in the New Policy Cycle: Full-chain Reconfiguration and Resilience Layout Driven by Digital Intelligence

Afternoon:SC Layout; E2E Visibility; Resilience & Agility; Logistics & SC Efficiency; Digital & AI

  ·  Supply Chain Layout and Strategies for Pharma Companies Going Global
  ·  Supply Chain Risk Management and Business Continuity Plan under Disruptions and Compliance Challenges
  ·  End-to-end Supply Chain Visibility and Integrated Collaboration between Upstream and Downstream
  ·  Forging Supply Chain Resilience and Agility to Navigate Future Uncertainties
  ·  Supply Chain Efficiency Improvement and Excellent Operation Driven by Digitalization and AI
  ·  Reshaping the Future of Business: The Next Generation of Autonomous Intelligent Supply Chain
  ·  Panel Discussion: How to Balance Compliance, Resilience, Cost and Efficiency in the Process of Reshaping Pharma Supply Chain?

22nd May: Value Chain Transformation; Clinical Supply Chain; Scale Up & Commercialization; Efficiency & Quality; Exhibition Tour;
Business Communication & Networking

Morning:Value Chain Transformation; Clinical Supply Chain; Scale Up & Commercialization; Efficiency & Quality

  ·  Value Chain Transformation - Supply Chain Improvements across the Entire Product Lifecycle
  ·  Cross-functional Connection and Collaboration to Deliver Better Clinical-to-Commercial Scale Up and Launch Management
  ·  Logistics Challenges in Clinical Trial Supply Chain: Cost, Efficiency, Quality and Compliance
  ·  Digitalization and AI Empower the Clinical Supply Chain to Achieve Cost reduction, Efficiency Improvement and Agile Operation
  ·  Panel Discussion: Digital, Intelligent and Collaborative Transformation of Clinical Supply Chain

Afternoon:Exhibition Tour; Business Communication & Networking

Speakers & Cooperation	Sponsors & Registration	Media Cooperation
_________________	_________________	_________________
Mr. Damon Woo Tel: 86 21 6077 8889*606 Mob: 136 8194 8168 Email: damon.woo@knggroup.com.cn	Mr. Jason Wang Tel: 86 21 6077 8889*602 Mob: 186 1630 5050 Email: jason.wang@knggroup.com.cn	Ms. Daisy Li Tel: 86 21 6077 8889*601 Email: daisy.li@knggroup.cn

2026 Global Pharma Supply Chain (China) Summit

“Digital & AI Driven, Future Supply Chain”